Abstract
Contrast-enhanced MR imaging with gadopentetate dimeglumine has been used in the evaluation of musculoskeletal disorders only in recent years, and for the most part it is still under investigation. Review of the literature identified potential uses for this technique: (1) in the spine, for differentiation between scar tissue and recurrent disk herniation and for evaluation of epidural tumors; (2) in musculoskeletal tumors, for differentiation between tumor necrosis and peritumoral edema and for characterization and evaluation of tumors before and after treatment; (3) in the joints for delineation of cartilage and tendon tears, with intraarticular injection, and for differentiation between pannus and joint effusion, with IV injection; and (4) for delineation of infectious processes. Further studies are needed to confirm most of these potential indications. It is unlikely that gadopentetate dimeglumine-enhanced MR imaging will become a routine part of musculoskeletal MR imaging, and its use will be reserved for specific circumstances.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.